From: The parent and family impact of CLN3 disease: an observational survey-based study
Age at diagnosis (n = 43), mean years (SD) | 8.2 (4.0) | |||
Symptomatic at diagnosis? n (%) | Yes 40 (93.0%) | No 3 (7.0%) | ||
Initial signs/symptoms noticed by caregiver | First (n = 40) | Second (n = 13) | Third (n = 5) | Fourth (n = 2) |
Decline in visual acuity 28 (70.0%) | Decline in visual acuity 6 (46.2%) | Decline in visual acuity 3 (60.0%) | Seizures 2 (100.0%) | |
Behavioral issues 5 (12.5%) | Behavioral issues 3 (23.1%) | Cognitive decline 1 (20.0%) | ||
Communication issues 3 (7.5%) | Communication issues 2 (15.4%) | Gross motor delay 1 (20.0%) | ||
Cognitive decline 1 (2.5%) | Cognitive decline 2 (15.4%) | |||
Seizures 1 (2.5%) | ||||
Symptom prevalence and onset (years) | Symptom present? | Mean age of onset, years (SD) | ||
Decline in visual acuity | 41 (95.3%) | 5.7 (1.2) | ||
Insomnia | 37 (86.0%) | 7.4 (3.6) | ||
Learning difficulties | 33 (76.7%) | 8.3 (4.1) | ||
Behavioral problems | 32 (74.4%) | 6.3 (4.1) | ||
Memory loss | 32 (74.4%) | 9.7 (4.0) | ||
Anxiety | 30 (69.8%) | 9.7 (5.9) | ||
Seizures | 28 (65.1%) | 10.5 (3.5) | ||
OCD | 28 (65.1%) | 8.1 (3.9) | ||
Ataxia | 24 (55.8%) | 12.4 (3.6) | ||
Depression | 17 (39.5%) | 11.7 (5.7) | ||
Missed milestones at checkups | 13 (30.2%) | 3.3 (2.3) |